Recent advances in the role of NKT cells in allergic diseases and asthma

Current Allergy and Asthma Reports

Volumn 8, Issue 2, 2008, Pages 165-170

  Stock, Philippe ^b   Akbari, Omid ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CORTICOSTEROID; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4;

AIRWAY; ALLERGIC DISEASE; ASTHMA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CHRONIC LUNG DISEASE; CHRONIC SINUSITIS; DISEASE CONTROL; EXPIRATORY RESERVE VOLUME; HUMAN; HYPERACTIVITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; INNATE IMMUNITY; LUNG BIOPSY; LUNG LAVAGE; NATURAL KILLER T CELL; NONHUMAN; PNEUMONIA; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TREATMENT DURATION; TREATMENT INDICATION;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE;

EID: 42149137962     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-008-0027-5     Document Type: Review

References (50)

1. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb Mortal Wkly Rep 1998, 47:1022-1025.
2. Umetsu D, McIntire J, Macaubas C, et al.: Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002, 3:715-720.
3. Kronenberg M, Gapin L: The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002, 2:557-568.
4. Smyth MJ, Crowe NY, Hayakawa Y, et al.: NKT cells: conductors of tumor immunity? Curr Opin Immunol 2002, 14:165-171.
5. Brutkiewicz RR, Sriram V: Natural killer T (NKT) cells and their role in antitumor immunity. Crit Rev Oncol Hematol 2002, 41:287-298.
6. Terabe M, Matsui S, Noben-Trauth N, et al.: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000, 1:515-520.
7. Sonoda KH, Faunce DE, Taniguchi M, et al.: NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001, 166:42-50.
8. Sonoda KH, Exley M, Snapper S, et al.: CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999, 190:1215-1226.
9. Seino KI, Fukao K, Muramoto K, et al.: Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001, 98:2577-2581.
10. Chargui J, Hase T, Wada S, et al.: NKT cells as nonspecific immune-regulator inducing tolerance in mouse model transplantation. Transplant Proc 2001, 33:3833-3834.
11. Ikehara Y, Yasunami Y, Kodama S, et al.: CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000, 105:1761-1767.
12. Ito K, Karasawa M, Kawano T, et al.: Involvement of decidual Valpha14 NKT cells in abortion. Proc Natl Acad Sci U S A 2000, 97:740-744.
13. Kita H, Naidenko OV, Kronenberg M, et al.: Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 2002, 123:1031-1043.
14. Forestier C, Molano A, Im JS, et al.: Expansion and hyperactivity of CD1d-restricted NKT cells during the progression of systemic lupus erythematosus in (New Zealand Black x New Zealand White)F1 mice. J Immunol 2005, 175:763-770.
15. Zeng D, Lewis D, Dejbakhsh-Jones S, et al.: Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999, 189:1073-81.
16. Kawakami K, Kinjo Y, Uezu K, et al.: Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 2001, 167:6525-6532.
17. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000, 192:921-930.
18. Schofield L, McConville MJ, Hansen D, et al.: CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999, 283:225-229.
19. Molano A, Park SH, Chiu YH, et al.: Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J Immunol 2000, 164:5005-5009.
20. Romero JF, Eberl G, MacDonald HR, Corradin G: CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice. Parasite Immunol 2001, 23:267-269.
21. Zaccone P, Fehervari Z, Jones FM, et al.: Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 2003, 33:1439-1449.
22. Mallevaey T, Zanetta JP, Faveeuw C, et al.: Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. J Immunol 2006, 176:2476-2485.
23. Wilson SB, Kent SC, Patton KT, et al.: Extreme Th1 bias of invariant Va24JaQ T cells in type 1 diabetes. Nature 1998, 391:177-181.
24. Miyamoto K, Miyake S, Yamamura T: A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001, 413:531-534.
25. Heller F, Fuss IJ, Nieuwenhuis EE, et al.: Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002, 17:629-638.
26. Akbari O, Stock P, Meyer E, et al.: Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003, 9:582-588.
27. Meyer EH, Goya S, Akbari O, et al.: Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperrcactivity independent of conventional CD4+ T cells. Proc Natl Acad Sci U S A 2006, 103:2782-2787.
28. Lisbonne M, Diem S, de Castro Keller A, et al.: Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003, 171:1637-1641.
29. Bilenki L, Yang J, Fan Y, et al.: Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur J Immunol 2004, 34:345-354.
30. Cui J, Watanabe N, Kawano T, et al.: Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med 1999, 190:783-792.
31. Jin N, Miyabara N, Roark CL, et al.: Airway hyperresponsiveness through synergy of {gamma)(delta} T cells and NKT cells. J Immunol 2007, 179:2961-2968.
32. Meyer EH, Wurbel MA, Staton TL, et al.: iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol 2007, 179:4661-4671.
33. Agea E, Russano A, Bistoni O, et al.: Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 2005, 202:295-308.
34. Sen Y, Yongyi B, Yuling H, et al.: V alpha 24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement. J Immunol 2005, 175:4914-4926.
35. Montoya CJ, Pollard D, Martinson J, et al.: Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007, 122:1-14.
36. Akbari O, Faul JL, Hoyte EG, et al.: CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med 2006, 354:1117-1129.
37. Hamzaoui A, Rouhou SC, Graïri H, et al.: NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm 2006:71214.
38. Yamamoto H, Okamoto Y, Horiguchi S, et al.: Detection of natural killer T cells in the sinus mucosa from asthmatics with chronic sinusitis. Allergy 2007, 62:1451-1455.
39. Sakuishi K, Oki S, Araki M, et al.: Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol 2007, 179:3452-3462.
40. Vijayanand P, Seumois G, Pickard C, et al.: Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med 2007, 356:1410-1422.
41. Thomas SY, Lilly CM, Luster AD: Invariant natural killer T cells in bronchial asthma. N Engl J Med 2006, 354:2613-2616.
42. Spinozzi F, Porcelli SA: Recognition of lipids from pollens by CD1-restricted T cells. Immunol Allergy Clin North Am 2007, 27:79-92.
43. Berzins SP, Cochrane AD, Pellicci DG, et al.: Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol 2005, 35:1399-1407.
44. Korosec P, Osolnik K, Kern I, et al.: Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis. Chest 2007, 132:1291-1297.
45. Hwang SJ, Kim S, Park WS, Chung DH: IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J Immunol 2006, 177:5258-5268.
46. Zhou D, Mattner J, Cantu C 3rd, et al.: Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306:1786-1789.
47. Kinjo Y, Wu D, Kim G, et al.: Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434:520-525.
48. Manner J, Debord KL, Ismail N, et al.: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
49. Kinjo Y, Tupin E, Wu D, et al.: Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006, 7:978-986.
50. Sullivan BA, Kronenberg M: Activation or anergy: NKT cells are stunned by alpha-galactosylceramide. J Clin Invest 2005, 115:2328-2329.